XML 18 R25.htm IDEA: XBRL DOCUMENT v3.20.1
Nature of the Business and Basis of Presentation - Additional Information (Detail) - USD ($)
3 Months Ended 173 Months Ended
Mar. 31, 2020
Dec. 17, 2019
Jul. 02, 2018
Mar. 31, 2020
Mar. 31, 2020
Apr. 21, 2020
Dec. 31, 2019
Dec. 29, 2017
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Entity incorporation date       Nov. 22, 2005        
Adjusted ownership value prior to closing merger   $ 40,000,000            
Additional enterprise value   5,000,000            
Cash valuation reduction $ 21,311              
Merger agreement minimum required net cash thresholds 30,000,000 $ 30,000,000   $ 30,000,000 $ 30,000,000      
Accumulated deficit 399,949,000     399,949,000 399,949,000   $ 396,351,000  
Net proceeds from sale of securities         397,900,000      
Credit facility default amount 300,000     300,000 300,000      
Total cash, cash equivalents and marketable securities 63,900,000     63,900,000 63,900,000      
Term Loan [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Aggregate principal balance 12,700,000     12,700,000 12,700,000     $ 20,000,000
Loan agreement minimum liquidity required 13,400,000     13,400,000 13,400,000   $ 15,300,000  
Credit facility default amount 300,000     300,000 300,000      
Public Offering [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Issuance of common stock     9,200,000          
Share price per share     $ 7.50          
Net proceeds from public offering, after underwriting discount, commission and offering expenses     $ 64,600,000          
Maximum [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Net cash threshold 40,500,000     40,500,000 40,500,000      
Minimum [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Net cash threshold 39,500,000     39,500,000 39,500,000      
Minimum [Member] | Subsequent Event [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Bid price of share as per rule           $ 1.00    
Minimum [Member] | Term Loan [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Total cash, cash equivalents and marketable securities 55,000,000     $ 55,000,000 $ 55,000,000      
Chondrial Security Holders [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Percentage of expected diluted common shares immediately after merger   60.00%            
Common stock, value immediately after merger   $ 67,500,000            
Increase in valuation of ownership $ 111,656              
Company Stockholders Prior to Merger [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Percentage of expected diluted common shares immediately after merger   40.00%            
Common stock, value immediately after merger   $ 45,000,000            
Chondrial Therapeutics Inc. [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Date of merger agreement   Dec. 17, 2019            
Merger agreement termination fee to be paid by either party to other party upon termination of agreement   $ 3,375,000            
Merger agreement minimum required net cash thresholds   $ 0            
Beneficiary interest percentage in outstanding common stock   9.70%            
Chondrial Therapeutics Inc. [Member] | Maximum [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Additional third party expenses to be paid by either party to other party upon termination of merger agreement   $ 350,000